Global Enteric Disease Testing and Therapeutic Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Enteric Disease Testing and Therapeutic Market Research Report 2024
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.
According to MRAResearch’s new survey, global Enteric Disease Testing and Therapeutic market is projected to reach US$ 3330.2 million in 2033, increasing from US$ 3014.3 million in 2022, with the CAGR of 1.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Enteric Disease Testing and Therapeutic market research.
According to World Health Organization (WHO), around 2.2 million people are killed annually due to food and water-borne diarrheal diseases. There is an impending global demand for better diagnostic and therapeutic options to prevent the deaths from enteric diseases.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Enteric Disease Testing and Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott
GlaxoSmithKline
Becton Dickinson
bioMérieux
Sanofi
Bayer Pharma
Bio-Rad
Quest Diagnostics
Trinity Biotech
Segment by Type
Bacterial Disease
Viral Disease
Parasitic Disease
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Enteric Disease Testing and Therapeutic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Enteric Disease Testing and Therapeutic market is projected to reach US$ 3330.2 million in 2033, increasing from US$ 3014.3 million in 2022, with the CAGR of 1.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Enteric Disease Testing and Therapeutic market research.
According to World Health Organization (WHO), around 2.2 million people are killed annually due to food and water-borne diarrheal diseases. There is an impending global demand for better diagnostic and therapeutic options to prevent the deaths from enteric diseases.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Enteric Disease Testing and Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
GlaxoSmithKline
Becton Dickinson
bioMérieux
Sanofi
Bayer Pharma
Bio-Rad
Quest Diagnostics
Trinity Biotech
Segment by Type
Bacterial Disease
Viral Disease
Parasitic Disease
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Enteric Disease Testing and Therapeutic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source